Fig 1.
Flow chart of this study.
Table 1.
Baseline clinical characteristics.
Table 2.
Angiographic, procedural characteristics and medications at discharge.
Fig 2.
Subgroups analysis for the impact of ACEI compared to that of ARB on (A) MACE, (B) stroke, (C) re-hospitalization due to HF at the 3-year follow-up using binary regression hazard ratio analysis in the IPTW population. The blue and red colors represent the lower and upper limits of 95% CI, respectively. ACEI, angiotensin-converting-enzyme inhibitors; ARB, angiotensin II type 1 receptor blockers; MACE, major adverse cardiac events; HF, heart failure; IPTW, inverse probability weighting.
Table 3.
Major clinical outcomes after acute myocardial infarction at 3 years.